certificate of analysis raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-15. Anything still debated is marked as such rather than presented as settled.
Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
| Property | Value | Notes |
|---|---|---|
| Storage form | Lyophilized powder | Longer stability at -20 °C |
| Reconstitution solvent | Sterile water or buffer | Depends on intended application |
| Purity assessment | Reverse-phase HPLC | Reported as peak area percentage |
| Identity confirmation | Mass spectrometry | Compared against theoretical mass |
| Main stability concern | Repeated freeze-thaw | May promote aggregation |
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
After subcutaneous dosing, peak plasma concentrations appear within roughly one hour, and elimination is fast, with a half-life on the order of a few hours. Degradation is mainly proteolytic, and at least one circulating fragment retains receptor activity, so parent-drug levels alone do not describe total exposure. Clearance does not depend heavily on hepatic cytochrome enzymes, which lowers the likelihood of common metabolic interaction routes. Data in renal or hepatic impairment are limited. Repeated dosing does not appear to produce marked accumulation given the short half-life.
Reported pharmacodynamic effects include transient rises in blood pressure and heart rate, flushing, nausea and headache, appearing soon after dosing and resolving within hours. These responses were dose-related in early studies and shaped the label's cardiovascular cautions and blood pressure monitoring advice. Gastrointestinal upset is the most frequent reason cited for discontinuation in trials. Whether the vascular signal attenuates with repeated use is not settled. Central effects on desire are described as emerging over weeks rather than immediately, which points to a cumulative rather than acute process.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
A&W Restaurants entered the Canadian market in 1956. In 1972, the American company sold the Canadian unit to Unilever thus creating A&W (Canada). In 1995, it was spun off into an independent entity with no ties to its American counterpart. They have over 800 locations nationwide.
Proponents of wheatgrass make many claims for its health properties, ranging from promotion of general well-being to cancer prevention. However, according to the American Cancer Society, "available scientific evidence does not support the idea that wheatgrass or the wheatgrass diet can cure or prevent disease". Several trials and clinical reports report benefits in specific conditions e.g., reduced transfusion needs in thalassemia, reduced some chemotherapy side effects, improvements in some inflammatory bowel disease metrics, or modest antioxidant marker changes. However, the trials are generally small, often short. Top reviews advise cautious interpretation and call for larger, better-designed trials.
The study of well-being originated in antiquity, often in the form of discussions on how to lead a good life. Socrates (c. 470 – c. 399 BCE) rejected power, fame, wealth, and the hedonistic pursuit of pleasure as paths to lasting happiness, arguing instead that wisdom and virtue are key elements of well-being. He held that lifelong learning and philosophical reflection cultivate an examined life, promote moral excellence, and align with the good. Influenced by Socrates, Aristotle (384–322 BCE) developed a eudaimonic theory of well-being. He maintained that well-being is the purpose of life and is achieved primarily by practicing virtues, such as acting in accordance with reason, justice, courage, and temperance. Aristotle distinguished three general factors that contribute to well-being: goods of the soul, such as intellectual and moral virtues; goods of the body, such as health; and external goods, such as wealth and good relations to others. In Hellenistic philosophy, starting in the 4th century BCE, the Epicureans and the Stoics considered well-being an internal state independent of external conditions. The Epicureans argued that pleasure is the only source of well-being and that it is best achieved through moderation and the cultivation of a tranquil state of mind. The Stoics emphasized discipline and rational virtue as the key to well-being.
=== Patent === Toward the end of January 1922, tensions mounted between the four "co-discoverers" of insulin and Collip briefly threatened to separately patent his purification process. John G. FitzGerald, director of the non-commercial public health institution Connaught Laboratories, therefore stepped in as peacemaker. The resulting agreement of 25 January 1922 established two key conditions: 1) that the collaborators would sign a contract agreeing not to take out a patent with a commercial pharmaceutical firm during an initial working period with Connaught; and 2) that no changes in research policy would be allowed unless first discussed among FitzGerald and the four collaborators. It helped contain disagreement and tied the research to Connaught's public mandate.
Sources: en.wikipedia.org
=== Depositional environments === Dinosaur eggs are known from a variety of depositional environments. Beach sands: Beach sands were a good place for dinosaurs to lay their eggs because the sand would be effective at absorbing and holding enough heat to incubate the eggs. One ancient beach deposit in northeastern Spain actually preserves about 300,000 fossil dinosaur eggs. Floodplains: Dinosaurs often laid their eggs on ancient floodplains. The mudstones deposited at these sites are therefore excellent sources of dinosaur egg fossils. Sand dunes: Many dinosaur eggs have been recovered from sandstone deposits that formed in the ancient dune fields of what are now northern China and Mongolia. The presence of Oviraptor preserved in their life brooding position suggests that the eggs, nests, and parents may have been rapidly buried by sandstorms.
=== Mechanism of action === Lumateperone acts as an antagonist at 5-HT2A receptors and binds to several dopamine receptors (D1, D2, and D4) with moderate affinity. It has moderate serotonin transporter reuptake inhibition, which is partly responsible for its antidepressant effect in bipolar disorder and reduction of negative symptoms of schizophrenia. It may also inhibit dopamine transporter reuptake, but more evidence is needed to confirm this. It has additional off-target antagonism at α1 receptors, without appreciable antimuscarinic or antihistaminergic properties, limiting side effects associated with other atypical antipsychotics, notably metabolic syndrome and hyperprolactinemia. Similar to aripiprazole, lumateperone acts as a partial agonist at inhibitory D2 autoreceptors and an antagonist at postsynaptic D2 receptors, thereby simultaneously reducing dopamine release and binding to postsynaptic receptors, respectively. However, lumateperone only occupies around 39% of D2 receptors—compared to at least 60-80% D2 occupancy for most antipsychotics to work for psychosis—and displays regioselectivity for the mesolimbic pathway, whose hyperactivity is responsible for the positive symptoms of schizophrenia. These qualities reduce the risk of extrapyramidal symptoms (EPS) from reduced dopaminergic transmission in the nigrostriatal pathway. A mechanism that is shared by all other atypical antipsychotics is antagonism of 5HT2A receptors, but, uniquely, lumateperone's affinity for these receptors is 60x higher than its affinity for D2 receptors.
On July 6, 2021, during the 2020 Summer Olympics, Brazil women's national volleyball team player Tandara was temporarily suspended for testing positive for enobosarm. The test was carried out and identified by the Brazilian Doping Control Authority (ABDC). On August 12, 2021, after the 2020 Summer Olympics, Chijindu "CJ" Ujah, A member of the silver medal-winning British 4×100 relay team was temporarily suspended for testing positive for both enobosarm and S-23. The sample was collected post event by the International Testing Agency (ITA) and confirmed two days later as positive. The case was referred to the anti-doping division of the Court of Arbitration for Sport. Finally in February 2022, Great Britain were stripped of their silver medal. In October 2022, Ujah was suspended for 22 months by the ITA. In October 2021, two Thoroughbred horses named Arafat and Komunist tested positive for enobosarm after races at Woodbine Racetrack. In a decision of the Alcohol and Gaming Commission of Ontario issued May 30, 2022, the horses were declared unplaced in the races in question, and their trainer Robert Gerl was fined $100,000 (as well as forfeiting prize money) and suspended from racing for 20 years. In May 2022, National Football League Wide receiver DeAndre Hopkins was suspended six games without pay by the NFL for violating the league's performance-enhancing drug policy. According to Hopkins, he tested positive for enobosarm.
Human iron metabolism is the set of chemical reactions that maintain human homeostasis of iron at the systemic and cellular level. Iron is both necessary to the body and potentially toxic. Controlling iron levels in the body is a critically important part of many aspects of human health and disease. Hematologists have been especially interested in systemic iron metabolism, because iron is essential for red blood cells, where most of the human body's iron is contained. Understanding iron metabolism is also important for understanding diseases of iron overload, such as hereditary hemochromatosis, and iron deficiency, such as iron-deficiency anemia. A 2024 review examined iron metabolism and its interactions with calcium, magnesium, and selected trace elements (copper, zinc, lead, cadmium, mercury, and nickel), as well as their roles in certain diseases.
Apollo 11 was prepared with the goal of a July landing in the Sea of Tranquility, just half a year after the first crewed flight to the Moon. The crew, selected in January 1969, consisted of commander (CDR) Neil Armstrong, Command Module Pilot (CMP) Michael Collins, and Lunar Module Pilot (LMP) Edwin "Buzz" Aldrin. They trained for the mission until just before the launch day. On July 16, 1969, at 9:32 am EDT, the Saturn V rocket, AS-506, lifted off from Kennedy Space Center Launch Complex 39 in Florida. The trip to the Moon took just over three days. After achieving orbit, Armstrong and Aldrin transferred into the Lunar Module named Eagle, leaving Collins in the Command and Service Module Columbia, and began their descent. Despite the interruption of alarms from an overloaded computer caused by an antenna switch left in the wrong position, Armstrong took over manual flight control at about 180 meters (590 ft) to correct a slight downrange guidance error, and set the Eagle down on a safe landing spot at 20:18:04 UTC, July 20, 1969 (3:17:04 pm CDT). Six hours later, at 02:56 UTC, July 21 (9:56 pm CDT July 20), Armstrong left the Eagle to become the first human to set foot on the Moon.
Sources: en.wikipedia.org
According to the 2025 Global Organized Crime Index, Pakistan had a criminality score of 6.32 out of 10, ranking 45th among 193 countries, and a resilience score ranking 131st among 193 countries, with the latter measuring the country's capacity to withstand and respond to organized crime. According to the Federal Investigation Agency's annual report, the agency received more than 73,000 cybercrime complaints in 2024, of which 1,604 were registered as cases, with financial fraud accounting for nearly half of all complaints. In 2025, the National Cyber Crimes Investigation Agency estimated that cybercrime had increased by about 35% compared with the previous year. A 2025 survey conducted on behalf of Visa Inc. found that 55% of respondents in Pakistan had fallen victim to an online scam in 2024, while 20% reported having been victims more than once. Pakistan scored 27 out of 100 on the Corruption Perceptions Index in 2024, ranking 135th out of 180 countries in the assessment of perceived public-sector corruption.
=== Generic names === Topilutamide is the generic name of the drug and its INNTooltip International Nonproprietary Name. It is also known more commonly as fluridil. Topilutamide is also known by its former developmental code name BP-766.
Later work making use of molecular evidence, with or without the use of morphological evidence, had by 2000 failed to resolve the argument. In 2011, on further molecular evidence, Janies and colleagues noted that the phylogeny of the echinoderms "has proven difficult", and that "the overall phylogeny of extant echinoderms remains sensitive to the choice of analytical methods". They presented a phylogenetic tree for the living Asteroidea only; using the traditional names of starfish orders where possible, and indicating "part of" otherwise, the phylogeny is shown below. The Solasteridae are split from the Velatida, and the old Spinulosida is broken up.
=== Design === Costume designer LJ Shannon "tried to stay as true to the [comics] lore as possible" in her designs. Each of the costumes are "utilitarian" with individual looks. Johns described Doctor Mid-Nite's as "[a] little steampunky" with canvas and leather and Hourman's as "a little more slick". Legacy Effects created a practical S.T.R.I.P.E. for use during filming.
== Distribution == Mealworms most-likely originated in the Mediterranean region, but are now present in many areas of the world as a result of human trade and colonization. The oldest archaeological records of mealworms can be traced to Bronze Age Turkey. Records from the British Isles and northern Europe are from a later date, and mealworms are conspicuously absent from archaeological finds from ancient Egypt.
Sources: en.wikipedia.org
Storage at -20 °C or below is standard for long-term stability. Desiccant and sealed containers limit moisture exposure. Solutions are prepared only when needed.
Reverse-phase HPLC separates components by hydrophobicity and reports purity as a percentage of total peak area. It does not by itself confirm molecular identity. Mass spectrometry is used alongside it for that purpose.
They link a specific lot to its analytical results and storage history. This traceability supports reproducibility when results differ between experiments. Records also help identify when re-testing is warranted.
PT-141 is a research code for bremelanotide, a cyclic peptide that activates melanocortin receptors. It was developed for sexual dysfunction and later approved under a brand name as a subcutaneous injection. The same code is widely used by suppliers selling non-pharmaceutical material.